L. S. Lashford

2.8k total citations
47 papers, 1.9k citations indexed

About

L. S. Lashford is a scholar working on Neurology, Genetics and Pulmonary and Respiratory Medicine. According to data from OpenAlex, L. S. Lashford has authored 47 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Neurology, 15 papers in Genetics and 14 papers in Pulmonary and Respiratory Medicine. Recurrent topics in L. S. Lashford's work include Neuroblastoma Research and Treatments (19 papers), Glioma Diagnosis and Treatment (14 papers) and Brain Metastases and Treatment (8 papers). L. S. Lashford is often cited by papers focused on Neuroblastoma Research and Treatments (19 papers), Glioma Diagnosis and Treatment (14 papers) and Brain Metastases and Treatment (8 papers). L. S. Lashford collaborates with scholars based in United Kingdom, India and United States. L. S. Lashford's co-authors include David Walker, James W. Ironside, David W. Ellison, Claire Weston, Roger Taylor, Barry Pizer, Clifford C. Bailey, J T Kemshead, H. Rao Gattamaneni and C. E. Hatton and has published in prestigious journals such as Proceedings of the National Academy of Sciences, The Lancet and Journal of Clinical Oncology.

In The Last Decade

L. S. Lashford

46 papers receiving 1.9k citations

Peers

L. S. Lashford
Chiaki Nakaseko Japan
Sophie Camilleri‐Broët France
Adela Cañete Spain
Christopher McPherson United States
Matteo Simonelli Italy
M.G. Glaser United Kingdom
Joohee Sul United States
Kirsten van Lom Netherlands
Josef Pichler Austria
Stefano Pizzolitto Italy
Chiaki Nakaseko Japan
L. S. Lashford
Citations per year, relative to L. S. Lashford L. S. Lashford (= 1×) peers Chiaki Nakaseko

Countries citing papers authored by L. S. Lashford

Since Specialization
Citations

This map shows the geographic impact of L. S. Lashford's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by L. S. Lashford with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites L. S. Lashford more than expected).

Fields of papers citing papers by L. S. Lashford

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by L. S. Lashford. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by L. S. Lashford. The network helps show where L. S. Lashford may publish in the future.

Co-authorship network of co-authors of L. S. Lashford

This figure shows the co-authorship network connecting the top 25 collaborators of L. S. Lashford. A scholar is included among the top collaborators of L. S. Lashford based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with L. S. Lashford. L. S. Lashford is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Grundy, Richard G., Claire Weston, L. S. Lashford, et al.. (2007). Primary postoperative chemotherapy without radiotherapy for intracranial ependymoma in children: the UKCCSG/SIOP prospective study. The Lancet Oncology. 8(8). 696–705. 163 indexed citations
2.
Taylor, Roger, Clifford C. Bailey, Kathryn J. Robinson, et al.. (2005). Outcome for patients with metastatic (M2–3) medulloblastoma treated with SIOP/UKCCSG PNET-3 chemotherapy. European Journal of Cancer. 41(5). 727–734. 115 indexed citations
3.
Taylor, Roger, Clifford C. Bailey, Kathryn J. Robinson, et al.. (2004). Impact of radiotherapy parameters on outcome in the International Society of Paediatric Oncology/United Kingdom Children's Cancer Study Group PNET-3 study of preradiotherapy chemotherapy for M0-M1 medulloblastoma. International Journal of Radiation Oncology*Biology*Physics. 58(4). 1184–1193. 49 indexed citations
4.
Lashford, L. S., Philippe Thiesse, Anne Jouvet, et al.. (2002). Temozolomide in malignant gliomas of childhood. Journal of Clinical Oncology. 20(24). 2 indexed citations
5.
Marples, Brian, Simon D. Scott, J H Hendry, et al.. (2000). Development of synthetic promoters for radiation-mediated gene therapy. Gene Therapy. 7(6). 511–517. 73 indexed citations
6.
7.
Wynn, Robert, Michael Cross, C. E. Hatton, et al.. (1998). Accelerated telomere shortening in young recipients of allogeneic bone-marrow transplants. The Lancet. 351(9097). 178–181. 185 indexed citations
8.
Lashford, L. S.. (1997). Possibilities of Gene Therapies for Cancer. Annals of Medicine. 29(1). 1–4. 7 indexed citations
9.
Kiltie, Anne E., L. S. Lashford, & H. Rao Gattamaneni. (1997). Survival and late effects in medulloblastoma patients treated with craniospinal irradiation under three years old. Medical and Pediatric Oncology. 28(5). 348–354. 86 indexed citations
10.
Lashford, L. S. & David Walker. (1997). Improving care for central nervous system tumours: a mood for change. Archives of Disease in Childhood. 76(2). 88–90. 22 indexed citations
11.
Eden, O B, Jillian M. Birch, Justine Y. Bruce, et al.. (1997). Pediatric Oncology and Hematology in Manchester, England. Pediatric Hematology and Oncology. 14(3). 191–197. 1 indexed citations
12.
Rafferty, Joseph A., Ian Hickson, L. S. Lashford, et al.. (1996). Chemoprotection of normal tissues by transfer of drug resistance genes. Cancer and Metastasis Reviews. 15(3). 365–383. 29 indexed citations
13.
Lashford, L. S.. (1994). Gene therapy for cancers.. Archives of Disease in Childhood. 71(6). 485–487. 2 indexed citations
14.
Flower, M. A., et al.. (1991). Dosimetry of iodine 131 metaiodobenzylguanidine for treatment of resistant neuroblastoma: results of a UK study. European Journal of Nuclear Medicine and Molecular Imaging. 18(5). 308–316. 48 indexed citations
15.
Lashford, L. S., Jeremy Hancock, & J. T. Kemshead. (1991). Meta‐Iodobenzylguanidine (mIBG) uptake and storage in the human neuroblastoma cell line SK‐N‐BE(2C). International Journal of Cancer. 47(1). 105–109. 42 indexed citations
16.
Bourne, Stephen P., Lucy F. Pemberton, R Moseley, et al.. (1989). Monoclonal Antibodies M340 and UJ181.4 Recognize Antigens Associated with Primitive Neuroectodermal Tumours/Tissues. Hybridoma. 8(4). 415–426. 16 indexed citations
17.
Lashford, L. S., Alun Davies, Richard B. Richardson, et al.. (1988). A pilot study of131I monoclonal antibodies in the therapy of leptomeningeal tumors. Cancer. 61(5). 857–868. 87 indexed citations
18.
Lashford, L. S., Judy S. Moyes, R.J. Ott, et al.. (1988). The biodistribution and pharmacokinetics of meta-iodobenzylguanidine in childhood neuroblastoma. European Journal of Nuclear Medicine and Molecular Imaging. 13(11). 574–577. 36 indexed citations
19.
Kemshead, J. T., et al.. (1987). Diagnosis and Therapy of Neuroectodermally Associated Tumours Using Targeted Radiation. Developmental Neuroscience. 9(2). 69–83. 8 indexed citations
20.
Kemshead, J. T., L. S. Lashford, Jeffrey W. Prichard, et al.. (1986). 131-I Coupled to Monoclonal Antibodies as Therapeutic Agents for Neuroectodermally Derived Tumors: Fact or Fiction?. PubMed. 3(1). 25–43. 22 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Chiaki Nakaseko Breakdown of academic impact, for papers by Sophie Camilleri‐Broët Breakdown of academic impact, for papers by Adela Cañete Breakdown of academic impact, for papers by Christopher McPherson Breakdown of academic impact, for papers by Matteo Simonelli Breakdown of academic impact, for papers by M.G. Glaser Breakdown of academic impact, for papers by Joohee Sul Breakdown of academic impact, for papers by Kirsten van Lom Breakdown of academic impact, for papers by Josef Pichler Breakdown of academic impact, for papers by Stefano Pizzolitto
Rankless by CCL
2026